華潤醫藥(03320.HK)訂立有限合夥協議
格隆匯7月17日丨華潤醫藥(03320.HK)公告,華潤醫藥(成都)企業管理合夥企業(有限合夥)(作爲普通合夥人)、華潤醫藥投資有限公司(公司的全資附屬公司)、華潤博雅生物製藥集團股份有限公司、東阿阿膠股份有限公司(公司的非全資附屬公司)、華潤雙鶴藥業股份有限公司(公司的非全資附屬公司)、江中藥業股份有限公司(公司的非全資附屬公司)、成都潤藥產業投資合夥企業(有限合夥)(基金投資團隊持有的僱員持股平臺,爲獨立第三方),以及五名其他獨立第三方(作爲有限合夥人)擬就成立合資基金(暫時名爲華潤醫藥(成都)創新投資基金合夥企業(有限合夥))訂立有限合夥協議,擬議規模爲人民幣10億元,總年期爲七年。集團的擬議資本承擔總額將約爲人民幣245百萬元,佔基金資本承擔總額約24.5%。
預期基金將主要從事股權投資、創業資本及投資管理活動,主要投資醫藥及健康產業以及戰略性新興領域。考慮到成都政府的產業政策及優惠措施,預期基金將重點投資於化學創新藥、生物藥(包括疫苗)、高端醫療器械(包括IVD)、中藥滋補品類、合成生物等領域的企業以及其他戰略性新興領域的企業。
相信集團可充分利用基金專業投資團隊的資源,通過基金有效控制併購及創新項目的風險,確保目標公司的質量,儲備優質戰略項目資源,並加速集團的戰略併購,從而實現其在醫藥行業的戰略目標,提升集團中長期的可持續發展能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.